Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
85.4M
-
Number of holders
-
110
-
Total 13F shares, excl. options
-
54.3M
-
Shares change
-
-749K
-
Total reported value, excl. options
-
$219M
-
Value change
-
-$1.67M
-
Put/Call ratio
-
3.04
-
Number of buys
-
51
-
Number of sells
-
-51
-
Price
-
$4.04
Significant Holders of Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) as of Q1 2024
131 filings reported holding AVIR - Atea Pharmaceuticals, Inc. - COMMON STOCK as of Q1 2024.
Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) has 110 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.3M shares
of 85.4M outstanding shares and own 63.6% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.24M shares), EcoR1 Capital, LLC (6.15M shares), FMR LLC (5.78M shares), BML Capital Management, LLC (5.54M shares), VANGUARD GROUP INC (4.72M shares), TANG CAPITAL MANAGEMENT LLC (4.08M shares), Bain Capital Life Sciences Investors, LLC (2.49M shares), GEODE CAPITAL MANAGEMENT, LLC (1.88M shares), STATE STREET CORP (1.68M shares), and RENAISSANCE TECHNOLOGIES LLC (1.12M shares).
This table shows the top 110 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.